What is Northland Securities’ Forecast for CHRN Q2 Earnings?

ChronoScale Corporation Common Stock (NASDAQ:CHRN) – Research analysts at Northland Securities issued their Q2 2026 earnings estimates for ChronoScale Corporation Common Stock in a research report issued to clients and investors on Friday, September 18th. Northland Securities analyst N. Chokshi anticipates that the company will post earnings per share of ($0.08) for the quarter. Northland Securities has a “Outperform” rating and a $32.00 price objective on the stock. The consensus estimate for ChronoScale Corporation Common Stock’s current full-year earnings is ($0.10) per share.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last issued its quarterly earnings results on Wednesday, August 19th. The company reported ($0.12) earnings per share for the quarter. The company had revenue of $18.40 million during the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%.

Separately, Weiss Ratings raised shares of ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a research note on Monday, August 24th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $19.00.

ChronoScale Corporation Common Stock Stock Down 3.3%

ChronoScale Corporation Common Stock stock opened at $20.51 on Tuesday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.51 and a current ratio of 0.51. ChronoScale Corporation Common Stock has a 52-week low of $3.50 and a 52-week high of $30.00. The firm has a 50 day moving average price of $21.30 and a two-hundred day moving average price of $17.34. The firm has a market cap of $2.99 billion, a price-to-earnings ratio of -3.81 and a beta of 0.98.

Institutional Investors Weigh In On ChronoScale Corporation Common Stock

A hedge fund recently raised its stake in ChronoScale Corporation Common Stock stock. Roble Belko & Company Inc grew its stake in shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) by 104.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,338 shares of the company’s stock after purchasing an additional 1,195 shares during the period. Roble Belko & Company Inc owned approximately 0.07% of ChronoScale Corporation Common Stock worth $25,000 as of its most recent filing with the Securities and Exchange Commission. 6.42% of the stock is owned by institutional investors and hedge funds.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.